HDL-C vs HDL-P: How Changing One Letter Could Make a Difference in Understanding the Role of High-Density Lipoprotein in Disease

疾病 高密度脂蛋白 脂蛋白 内科学 医学 动脉粥样硬化性心血管疾病 胆固醇 心理学
作者
W. Sean Davidson
出处
期刊:Clinical Chemistry [American Association for Clinical Chemistry]
卷期号:60 (11): e1-e3 被引量:26
标识
DOI:10.1373/clinchem.2014.232769
摘要

Before about 2006, most papers focusing on high-density lipoprotein (HDL)2 contained an introductory sentence that touted its protective role against cardiovascular disease (CVD), usually via the reverse transport of cholesterol away from the vessel wall. This was based on a mountain of epidemiological evidence showing an inverse correlation between plasma concentrations of HDL cholesterol (HDL-C) and CVD as well as thousands of in vitro and animal model studies demonstrating the cholesterol-carrying capacity of the particles. More recently, however, confidence in a direct atheroprotective role for HDL has wavered. HDL-targeted drugs such as niacin and 2 different cholesteryl ester transfer protein (CETP) inhibitors have failed in clinical trials, despite raising HDL-C (nicely reviewed in (1)). Furthermore, recent Mendelian randomization analyses suggest that genetic anomalies that raise HDL-C fail to impart the CVD protections predicted by epidemiologic findings (2). This has prompted some to regard HDL as a marker or byproduct of other, more directly atheroprotective, mechanisms. On the other hand, large studies have shown that the cholesterol efflux capacity of primarily HDL-containing [i.e., low-density lipoprotein (LDL)-depleted] serum is a robust predictor of CVD, even better than HDL-C (3), suggesting that HDL's mobilization of cellular cholesterol may indeed be atheroprotective. So why has it been so difficult to determine whether HDL plays a direct protective role in CVD? Some argue that the picture has been clouded by the way HDL has been traditionally quantified. The HDL-C measurement targets only a single HDL component, and a relatively minor one at that: a maximum of 20% of HDL mass is cholesterol or its ester. Ideally, one would like to know the actual number of HDL particles (HDL-P) circulating in plasma, not simply how much cholesterol they are carrying. This is a relatively easy determination for LDL. Because each particle contains a single copy …
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
李海平完成签到 ,获得积分10
1秒前
聪慧的从雪完成签到 ,获得积分10
5秒前
安详的语蕊完成签到,获得积分10
8秒前
淡然的剑通完成签到 ,获得积分10
9秒前
Holly完成签到,获得积分10
11秒前
科研王子完成签到,获得积分10
11秒前
宇文雨文给宇文雨文的求助进行了留言
13秒前
Ly完成签到 ,获得积分10
16秒前
23完成签到,获得积分10
18秒前
PHI完成签到 ,获得积分10
19秒前
叶未晞yi完成签到,获得积分10
21秒前
drjyang完成签到,获得积分10
25秒前
29秒前
乔巴完成签到 ,获得积分10
31秒前
正直冰露完成签到 ,获得积分10
32秒前
十月天秤完成签到,获得积分10
35秒前
36秒前
香蕉觅云应助宇文雨文采纳,获得30
38秒前
健壮惋清完成签到 ,获得积分10
38秒前
zhangguo完成签到 ,获得积分10
38秒前
HHM完成签到,获得积分10
39秒前
lalala完成签到 ,获得积分10
41秒前
细心的安双完成签到 ,获得积分10
41秒前
宋芽芽u发布了新的文献求助10
42秒前
pK完成签到 ,获得积分10
42秒前
群青完成签到 ,获得积分10
45秒前
叶子完成签到,获得积分10
46秒前
48秒前
ZDM6094完成签到 ,获得积分10
49秒前
叶子完成签到,获得积分10
49秒前
49秒前
杨涵完成签到 ,获得积分10
52秒前
小龙发布了新的文献求助10
54秒前
SCI完成签到 ,获得积分10
57秒前
雨寒完成签到 ,获得积分10
59秒前
糊糊完成签到 ,获得积分10
1分钟前
小龙完成签到,获得积分10
1分钟前
Tom完成签到,获得积分10
1分钟前
1分钟前
byby完成签到,获得积分10
1分钟前
高分求助中
Pipeline and riser loss of containment 2001 - 2020 (PARLOC 2020) 1000
哈工大泛函分析教案课件、“72小时速成泛函分析:从入门到入土.PDF”等 660
Comparing natural with chemical additive production 500
The Leucovorin Guide for Parents: Understanding Autism’s Folate 500
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 500
A Manual for the Identification of Plant Seeds and Fruits : Second revised edition 500
The Social Work Ethics Casebook: Cases and Commentary (revised 2nd ed.) 400
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 5212420
求助须知:如何正确求助?哪些是违规求助? 4388601
关于积分的说明 13664165
捐赠科研通 4249133
什么是DOI,文献DOI怎么找? 2331417
邀请新用户注册赠送积分活动 1329109
关于科研通互助平台的介绍 1282517